GlassScriptPhysician profile
Michael W West
NPI 1841354065
$3,123.73
in general payments reported to CMS, 2019-2025
10 companies · $13.88 in 2025
The $13.88 reported for 2025 was less than what a typical Trauma Surgery provider received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,265 · 2020: $342 · 2021: $114 · 2022: $24.17 · 2023: $16.43 · 2024: $348 · 2025: $13.88.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $378.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $378.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,299.83 | 2019 | |
| Depuy Synthes Sales INC. | $1,071.18 | 2019-2020 | |
| Davol INC. | $311.56 | 2024 | Phasix Mesh |
| Cumberland Pharmaceuticals, INC. | $310.28 | 2019-2024 | Caldolor |
| Janssen Pharmaceuticals, INC | $46.20 | 2022-2024 | Xarelto |
| Chiesi USA, INC. | $21.72 | 2020 | |
| Acell, INC. | $17.44 | 2020 | |
| Organogenesis INC. | $16.43 | 2023 | Puraply |
| Pfizer INC. | $15.21 | 2019 | |
| Atricure, INC. | $13.88 | 2025 | Atricure Cryoice Cryosphere Cryoablation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael West listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.